COR Cencora Inc.

  1. Stocks
  2. Healthcare
  3. NYSE: COR

Price (delayed)

$180.165

Market cap

$36.42B

P/E Ratio

21.71

Dividend/share

$1.94

EPS

$8.3

Enterprise value

$40.06B

amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in ...

Highlights
The equity has soared by 144% from the previous quarter
The company's debt fell by 17% YoY
The company's net income fell by 8% YoY but it rose by 4.5% QoQ
COR's EPS is down by 6% year-on-year but it is up by 5% since the previous quarter
COR's P/E is 24% above its 5-year quarterly average of 17.7 and 10% above its last 4 quarters average of 20.0
The company's quick ratio fell by 6% YoY
Sector: Healthcare
Industry: Medical Distribution
Website: https://www.amerisourcebergen.com/
Peers: EQIX PMT CTRE NNN

Key stats

What are the main financial stats of COR
Market
Shares outstanding
202.17M
Market cap
$36.42B
Enterprise value
$40.06B
Valuations
Price to earnings (P/E)
21.71
Price to book (P/B)
53.17
Price to sales (P/S)
0.14
EV/EBIT
17.24
EV/EBITDA
14.68
EV/Sales
0.16
Earnings
Revenue
$254.43B
EBIT
$2.32B
EBITDA
$2.73B
Free cash flow
$2.8B
Per share
EPS
$8.3
Free cash flow per share
$13.83
Book value per share
$3.39
Revenue per share
$1,257.36
TBVPS
$231.05
Balance sheet
Total assets
$61.18B
Total liabilities
$60.26B
Debt
$5.02B
Equity
$686.02M
Working capital
-$5.8B
Liquidity
Debt to equity
7.32
Current ratio
0.88
Quick ratio
0.47
Net debt/EBITDA
1.33
Margins
EBITDA margin
1.1%
Gross margin
3.4%
Net margin
0.7%
Operating margin
0.9%
Efficiency
Return on assets
2.9%
Return on equity
1,169.2%
Return on invested capital
72.6%
Return on capital employed
16.1%
Return on sales
0.9%
Dividend
Dividend yield
1.08%
DPS
$1.94
Payout ratio
23.4%

COR stock price

How has the Cencora stock price performed over time
Intraday
-1.47%
1 week
-3.11%
1 month
0.1%
1 year
32.41%
YTD
8.72%
QTD
-6.37%

Financial performance

How have Cencora's revenue and profit performed over time
Revenue
$254.43B
Gross profit
$8.69B
Operating income
$2.32B
Net income
$1.69B
Gross margin
3.4%
Net margin
0.7%
The company's net margin fell by 13% YoY
Cencora's operating margin has decreased by 10% YoY
The operating income has grown by 9% from the previous quarter but it has contracted by 6% YoY
The company's net income fell by 8% YoY but it rose by 4.5% QoQ

Growth

What is Cencora's growth rate over time

Valuation

What is Cencora stock price valuation
COR P/E details
P/E
21.71
P/B
53.17
P/S
0.14
EV/EBIT
17.24
EV/EBITDA
14.68
EV/Sales
0.16
COR's P/E is 24% above its 5-year quarterly average of 17.7 and 10% above its last 4 quarters average of 20.0
COR's EPS is down by 6% year-on-year but it is up by 5% since the previous quarter
The equity has soared by 144% from the previous quarter
The P/S is 50% above the 5-year quarterly average of 0.1 and 50% above the last 4 quarters average of 0.1
Cencora's revenue has increased by 8% YoY and by 2.8% QoQ

Efficiency

How efficient is Cencora business performance
The ROE has soared by 97% year-on-year but it has dropped by 79% since the previous quarter
Cencora's ROIC has increased by 35% YoY and by 6% from the previous quarter
COR's return on sales is down by 18% year-on-year
The company's return on assets fell by 9% YoY but it rose by 3.6% QoQ

Dividends

What is COR's dividend history
Dividend details
DPS
$1.94
Dividend yield
1.08%
Payout ratio
23.4%
Recent dividends

Financial health

How did Cencora financials performed over time
COR's total assets is up by 7% year-on-year and by 4.1% since the previous quarter
Cencora's total liabilities has increased by 6% YoY and by 3.4% from the previous quarter
The equity has soared by 144% from the previous quarter
The debt to equity has dropped by 73% year-on-year and by 58% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.